about
Molecular mechanism of WW-domain binding protein-2 coactivation function in estrogen receptor signalingH3K27 demethylation by JMJD3 at a poised enhancer of anti-apoptotic gene BCL2 determines ERα ligand dependencyProliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ERα and growth factors via MAPK pathwayThe Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosisPrognostic molecular markers in early breast cancerThe p53-dependent apoptotic pathway of breast cancer cells (BC-M1) induced by the bis-type bioreductive compound aziridinylnaphthoquinoneAdvances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapyAdvances in the Molecular Analysis of Breast Cancer: Pathway Toward Personalized MedicineThe role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not?Parabens and Human Epidermal Growth Factor Receptor Ligand Cross-Talk in Breast Cancer CellsHigh content imaging-based assay to classify estrogen receptor-α ligands based on defined mechanistic outcomes.Large scale gene expression profiles of regenerating inner ear sensory epithelia.Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer.Estrogen regulation of TRPM8 expression in breast cancer cells.In vitro metabolism of exemestane by hepatic cytochrome P450s: impact of nonsynonymous polymorphisms on formation of the active metabolite 17β-dihydroexemestaneImmunotherapeutic target expression on breast tumors can be amplified by hormone receptor antagonism: a novel strategy for enhancing efficacy of targeted immunotherapyClassical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cellsBreast tumor developed in a pregnant rat after treatment with the teratogen CycloheximideDown-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cellsCollagen-IV and laminin-1 regulate estrogen receptor alpha expression and function in mouse mammary epithelial cells.Serine protease PRSS23 is upregulated by estrogen receptor α and associated with proliferation of breast cancer cells.Chromatin exposes intrinsic differences in the transcriptional activities of estrogen receptors alpha and beta.A prognosis classifier for breast cancer based on conserved gene regulation between mammary gland development and tumorigenesis: a multiscale statistical model.Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fosSuppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis.The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1.Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α.Genomic classification of the RAS network identifies a personalized treatment strategy for lung cancerBody mass index associated with genome-wide methylation in breast tissue.Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression.Estrogen regulates JNK1 genomic localization to control gene expression and cell growth in breast cancer cellsToward a systems biology of mouse inner ear organogenesis: gene expression pathways, patterns and network analysis.SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells.MGMT inhibition restores ERα functional sensitivity to antiestrogen therapyTargeting Brn-3b in breast cancer therapy.Jostling for position: optimizing linker location in the design of estrogen receptor-targeting PROTACs.Cancer-linked targets modulated by curcumin
P2860
Q24305590-ED7CF846-C8B9-457F-9095-A9B32A90CB75Q24322697-0648C986-9DBA-4D2F-928D-B97A3D838D16Q24337280-84F9CB01-4514-46A4-A717-713D53E337E6Q24622720-5664A112-26A5-419E-A825-BC214C4D5C23Q24794845-991BD981-CB8A-40DD-954C-657BC94919CDQ24796330-267EB37C-7EAB-4F13-B74B-EC5B2AA081F6Q24803990-7694CAF2-6949-44EF-A6E9-D38F0698F1D9Q27001994-DFFB2D2F-68D5-4E72-B26F-56A8985B7D6BQ28390036-D445B548-3F42-42DD-B6B8-AAE2E55D972CQ29109837-F80CF844-5952-4F92-89D4-2333D14F665EQ30500039-027C33A8-E784-44BE-8AB3-67015BB3979CQ30544225-20E7A231-72E9-43D7-A9B6-0B8289FB0592Q33339736-BA8736E7-EF5B-41DC-B538-FC0C9E114F49Q33581314-EB0B2801-2001-44CA-8CD5-26A3A11414FFQ33777963-CE547213-EC93-40EC-8A57-43AB82ADF133Q33779152-C3253A54-4ED5-4950-966F-4B8C5359919DQ33903965-FE9AF9D4-B855-4B8E-8C9D-78A94229FFE5Q33925127-B3900DA4-D432-4C86-88C2-0DFAF61D8BE9Q33939484-8F4B27E2-3727-49A2-8F63-B81457B4910AQ33953912-7DBBDC4E-AF8C-49EE-8031-07FF7196551CQ34042070-606EB9F7-97E6-465F-AC7E-6979AD4692D4Q34103456-049173DC-C0D2-49B1-9394-30CBE2B55869Q34146042-EB7419EA-7BC1-45B5-964E-D4885BF09A7DQ34463619-795E3EA2-B48A-4749-9AAC-3E77E0A99AB8Q34658145-B50BDA8F-6BAB-433F-86D7-7388EAC4A29EQ35121907-2E584D97-10DD-4396-AE93-D2685C39E621Q35221417-33607936-C2CE-4007-A6FC-61558EF7A302Q35275278-50259D2C-8F4D-4611-B0F5-EED7DEAD63BCQ35662252-055B08FE-97BB-477B-9CBE-274A33B05C40Q35670290-4C02CD68-87A5-4D45-A7EF-CB0D5A102349Q35760105-9E8061E2-0C1B-4EB2-8047-A7F8C48B069FQ35769433-9DF21C26-E5AC-40F9-9BA7-AFCAE4FB5BDAQ35970128-7DB720E5-D48C-4F1E-A68E-08D2940E9075Q36052331-1EA3E854-4A3A-4139-A9D6-8D8F00ECCB01Q36154555-543EE663-45F6-4F37-B0D4-6BF73A352C44Q36180128-5D9493AC-414A-45EB-9A3E-D413CD143A44Q36283445-0589BA39-D717-409D-905F-2DF2C260C609Q36379362-847D750D-E880-4BD0-A458-128B45565957Q36452355-08C0B656-F1FC-4AAE-ACF4-289F1FA01102Q36499048-13467660-FC0B-40F5-A3D4-7265B386AE47
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Estrogen receptor and breast cancer.
@ast
Estrogen receptor and breast cancer.
@en
Estrogen receptor and breast cancer.
@nl
type
label
Estrogen receptor and breast cancer.
@ast
Estrogen receptor and breast cancer.
@en
Estrogen receptor and breast cancer.
@nl
prefLabel
Estrogen receptor and breast cancer.
@ast
Estrogen receptor and breast cancer.
@en
Estrogen receptor and breast cancer.
@nl
P356
P1476
Estrogen receptor and breast cancer.
@en
P2093
P304
P356
10.1006/SCBI.2001.0389
P577
2001-10-01T00:00:00Z